Basit öğe kaydını göster

Aneuploidy index in blood: A potential marker for early onset, androgen response, and metastasis in human prostate cancer

dc.contributor.authorJohnston , D.
dc.contributor.authorHopwood , V. L.
dc.contributor.authorÖZEN, Mustafa
dc.contributor.authorPathak, S.
dc.contributor.authorvon Eschenbach , A.C.
dc.contributor.authorLogothetis , C.J.
dc.contributor.authorBabaian , R.J.
dc.date.accessioned2021-03-05T16:04:36Z
dc.date.available2021-03-05T16:04:36Z
dc.date.issued1999
dc.identifier.citationÖZEN M., Hopwood V. L. , Johnston D., Babaian R., Logothetis C., von Eschenbach A., Pathak S., "Aneuploidy index in blood: A potential marker for early onset, androgen response, and metastasis in human prostate cancer", UROLOGY, cilt.53, ss.381-385, 1999
dc.identifier.issn0090-4295
dc.identifier.otherav_bee17937-57e2-42fe-a62e-123a56f2d3c0
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/126761
dc.identifier.urihttps://doi.org/10.1016/s0090-4295(98)00487-7
dc.description.abstractObjectives. To investigate whether the frequency of chromosome abnormalities in peripheral blood lymphocytes defined as the aneuploidy index in blood (AnIB) can be used as a clinical marker of early age onset, androgen response, and metastasis in human prostate cancer.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectNefroloji
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectKlinik Tıp
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.titleAneuploidy index in blood: A potential marker for early onset, androgen response, and metastasis in human prostate cancer
dc.typeMakale
dc.relation.journalUROLOGY
dc.contributor.department, ,
dc.identifier.volume53
dc.identifier.issue2
dc.identifier.startpage381
dc.identifier.endpage385
dc.contributor.firstauthorID624912


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster